The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
me change notification emails
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
Funding Opportunity Number:
Jan 20, 2012
Jan 20, 2012
Original Closing Date for Applications:
Mar 28, 2012
Current Closing Date for Applications:
Mar 28, 2012
Jun 28, 2012
Funding Instrument Type:
Category of Funding Activity:
Science and Technology and other Research and Development
Expected Number of Awards:
Estimated Total Program Funding:
Office of Science Financial Assistance Program
Cost Sharing or Matching Requirement:
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
All types of entities are eligible to apply, except other Federal agencies, Federally Funded Research and Development Center (FFRDC) Contractors, and nonprofit organizations described in section 501(c)(4) of the Internal Revenue Code of 1986 that engaged in lobbying activities after December 31, 1995. Synergistic collaborations with researchers in Federal Laboratories and Federally Funded Research and Development Centers (FFRDCs), including the DOE National Laboratories are permitted. Collaborations should be limited to filling critical voids in expertise and can represent no more than 50 percent of the total budget.
Office of Science
The U.S. Department of Energy's Office of Science, Office of Biological and Environmental Research (BER) hereby announces its interest in receiving applications for potential funding of Integrated Nuclear Medicine Research and Training Projects of Excellence to serve three important goals:
1. Research and development of new and highly innovative radiotracer methods and radiotracers as potential imaging agents for nuclear medicine research and application to advance the understanding of normal human physiology and gene expression, diagnosis and management of disease, in drug research and development, and in translational science;
2. Integrated involvement of postdoctoral fellows (Ph.D. radiochemists) and M.D., or M.D.-Ph.D fellows with specialties in Nuclear Medicine with applications to human health in developing and deploying new radiotracers for nuclear medicine imaging and potential clinical use in humans for disease-specific applications; and
3. Enhancement of training opportunities to ensure the future availability of human resources for highly specialized fields of radiotracer development chemistry and clinical nuclear medicine research and allied disciplines.
Applicants must have access to existing advanced facilities and an interdisciplinary collaborative team of radiochemists, synthetic chemists, biochemists and other expertise including physician scientists specialized in human disease- or disorder-specific nuclear medicine imaging, with the ability to support a robust research training environment. Institutional settings with easy access to nuclear medicine imaging specialties such as positron emission tomography (PET) and SPECT (single photon emission computed tomography) are required and should offer broad ranging research collaborations from research and development of radiotracers to translation for potential clinical use in humans. For further details, refer to the provided supplementary information.